Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinoma

ObjectivesTo evaluate the predictive role of pre-nephroureterectomy (NU) hydronephrosis on post-NU renal function (RF) change and preserved eligibility rate for adjuvant therapy in patients with upper tract urothelial carcinoma (UTUC).Patients and methodsThis retrospective study collected data of 10...

Full description

Bibliographic Details
Main Authors: Pai-Yu Cheng, Hsiang-Ying Lee, Wei-Ming Li, Steven K. Huang, Chien-Liang Liu, I-Hsuan Alan Chen, Jen-Tai Lin, Chi-Wen Lo, Chih-Chin Yu, Shian-Shiang Wang, Chuan-Shu Chen, Jen-Shu Tseng, Wun-Rong Lin, Jou Yeong-Chin, Ian-Seng Cheong, Yuan-Hong Jiang, Yu Khun Lee, Yung-Tai Chen, Shin-Hong Chen, Bing-Juin Chiang, Thomas Y. Hsueh, Chao-Yuan Huang, Chia-Chang Wu, Wei Yu Lin, Yao-Chou Tsai, Kai-Jie Yu, Chi-Ping Huang, Yi-You Huang, Chung-You Tsai
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.944321/full
_version_ 1797895401089531904
author Pai-Yu Cheng
Pai-Yu Cheng
Hsiang-Ying Lee
Hsiang-Ying Lee
Hsiang-Ying Lee
Hsiang-Ying Lee
Wei-Ming Li
Wei-Ming Li
Wei-Ming Li
Wei-Ming Li
Wei-Ming Li
Steven K. Huang
Steven K. Huang
Chien-Liang Liu
I-Hsuan Alan Chen
Jen-Tai Lin
Chi-Wen Lo
Chih-Chin Yu
Chih-Chin Yu
Shian-Shiang Wang
Shian-Shiang Wang
Shian-Shiang Wang
Chuan-Shu Chen
Chuan-Shu Chen
Chuan-Shu Chen
Jen-Shu Tseng
Jen-Shu Tseng
Jen-Shu Tseng
Wun-Rong Lin
Wun-Rong Lin
Jou Yeong-Chin
Jou Yeong-Chin
Ian-Seng Cheong
Yuan-Hong Jiang
Yu Khun Lee
Yung-Tai Chen
Shin-Hong Chen
Bing-Juin Chiang
Bing-Juin Chiang
Bing-Juin Chiang
Thomas Y. Hsueh
Thomas Y. Hsueh
Chao-Yuan Huang
Chia-Chang Wu
Chia-Chang Wu
Chia-Chang Wu
Wei Yu Lin
Wei Yu Lin
Wei Yu Lin
Yao-Chou Tsai
Yao-Chou Tsai
Yao-Chou Tsai
Kai-Jie Yu
Kai-Jie Yu
Kai-Jie Yu
Chi-Ping Huang
Chi-Ping Huang
Yi-You Huang
Chung-You Tsai
Chung-You Tsai
author_facet Pai-Yu Cheng
Pai-Yu Cheng
Hsiang-Ying Lee
Hsiang-Ying Lee
Hsiang-Ying Lee
Hsiang-Ying Lee
Wei-Ming Li
Wei-Ming Li
Wei-Ming Li
Wei-Ming Li
Wei-Ming Li
Steven K. Huang
Steven K. Huang
Chien-Liang Liu
I-Hsuan Alan Chen
Jen-Tai Lin
Chi-Wen Lo
Chih-Chin Yu
Chih-Chin Yu
Shian-Shiang Wang
Shian-Shiang Wang
Shian-Shiang Wang
Chuan-Shu Chen
Chuan-Shu Chen
Chuan-Shu Chen
Jen-Shu Tseng
Jen-Shu Tseng
Jen-Shu Tseng
Wun-Rong Lin
Wun-Rong Lin
Jou Yeong-Chin
Jou Yeong-Chin
Ian-Seng Cheong
Yuan-Hong Jiang
Yu Khun Lee
Yung-Tai Chen
Shin-Hong Chen
Bing-Juin Chiang
Bing-Juin Chiang
Bing-Juin Chiang
Thomas Y. Hsueh
Thomas Y. Hsueh
Chao-Yuan Huang
Chia-Chang Wu
Chia-Chang Wu
Chia-Chang Wu
Wei Yu Lin
Wei Yu Lin
Wei Yu Lin
Yao-Chou Tsai
Yao-Chou Tsai
Yao-Chou Tsai
Kai-Jie Yu
Kai-Jie Yu
Kai-Jie Yu
Chi-Ping Huang
Chi-Ping Huang
Yi-You Huang
Chung-You Tsai
Chung-You Tsai
author_sort Pai-Yu Cheng
collection DOAJ
description ObjectivesTo evaluate the predictive role of pre-nephroureterectomy (NU) hydronephrosis on post-NU renal function (RF) change and preserved eligibility rate for adjuvant therapy in patients with upper tract urothelial carcinoma (UTUC).Patients and methodsThis retrospective study collected data of 1018 patients from the Taiwan UTUC Collaboration Group registry of 26 institutions. The patients were divided into two groups based on the absence or presence of pre-NU hydronephrosis. Estimated glomerular filtration rate (eGFR) was calculated pre- and post-NU respectively. The one month post-NU RF change, chronic kidney disease (CKD) progression, and the preserved eligibility rate for adjuvant therapy were compared for each CKD stage.Results404 (39.2%) patients without and 614 (60.8%) patients with pre-NU hydronephrosis were enrolled. The median post-NU change in the eGFR was significantly lower in the hydronephrosis group (-3.84 versus -12.88, p<0.001). Pre-NU hydronephrosis was associated with a lower post-NU CKD progression rate (33.1% versus 50.7%, p< 0.001) and was an independent protective factor for RF decline after covariate adjustment (OR=0.46, p<0.001). Patients with pre-NU hydronephrosis had a higher preserved eligibility rate for either adjuvant cisplatin-based chemotherapy (OR=3.09, 95%CI 1.95–4.69) or immune-oncology therapy (OR=2.31, 95%CI 1.23–4.34).ConclusionPre-NU hydronephrosis is an independent protective predictor for post-NU RF decline, CKD progression, and eligibility for adjuvant therapy. With cautious selection for those unfavorably prognostic, non-metastatic UTUC patients with preoperative hydronephrosis, adjuvant rather than neoadjuvant therapy could be considered due to higher chance of preserving eligibility.
first_indexed 2024-04-10T07:26:17Z
format Article
id doaj.art-4ea38292d28c47159b3676ea62024aed
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-10T07:26:17Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-4ea38292d28c47159b3676ea62024aed2023-02-24T06:43:12ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-02-011310.3389/fonc.2023.944321944321Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinomaPai-Yu Cheng0Pai-Yu Cheng1Hsiang-Ying Lee2Hsiang-Ying Lee3Hsiang-Ying Lee4Hsiang-Ying Lee5Wei-Ming Li6Wei-Ming Li7Wei-Ming Li8Wei-Ming Li9Wei-Ming Li10Steven K. Huang11Steven K. Huang12Chien-Liang Liu13I-Hsuan Alan Chen14Jen-Tai Lin15Chi-Wen Lo16Chih-Chin Yu17Chih-Chin Yu18Shian-Shiang Wang19Shian-Shiang Wang20Shian-Shiang Wang21Chuan-Shu Chen22Chuan-Shu Chen23Chuan-Shu Chen24Jen-Shu Tseng25Jen-Shu Tseng26Jen-Shu Tseng27Wun-Rong Lin28Wun-Rong Lin29Jou Yeong-Chin30Jou Yeong-Chin31Ian-Seng Cheong32Yuan-Hong Jiang33Yu Khun Lee34Yung-Tai Chen35Shin-Hong Chen36Bing-Juin Chiang37Bing-Juin Chiang38Bing-Juin Chiang39Thomas Y. Hsueh40Thomas Y. Hsueh41Chao-Yuan Huang42Chia-Chang Wu43Chia-Chang Wu44Chia-Chang Wu45Wei Yu Lin46Wei Yu Lin47Wei Yu Lin48Yao-Chou Tsai49Yao-Chou Tsai50Yao-Chou Tsai51Kai-Jie Yu52Kai-Jie Yu53Kai-Jie Yu54Chi-Ping Huang55Chi-Ping Huang56Yi-You Huang57Chung-You Tsai58Chung-You Tsai59Institute of Biomedical Engineering, National Taiwan University, Taipei, TaiwanDivisions of Urology, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, TaiwanDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung, TaiwanDepartment of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, TaiwanGraduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung, TaiwanDepartment of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Urology, Ministry of Health and Welfare Pingtung Hospital, Pingtung, TaiwanCohort Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan0Division of Urology, Department of Surgery, Chi Mei Medical Center, Tainan, Taiwan1Department of Medical Science Industries, College of Health Sciences, Chang Jung Christian University, Tainan, Taiwan0Division of Urology, Department of Surgery, Chi Mei Medical Center, Tainan, Taiwan2Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan2Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan3Division of Urology, Department of Surgery, Taipei Tzu Chi Hospital, The Buddhist Medical Foundation, New Taipei City, Taiwan3Division of Urology, Department of Surgery, Taipei Tzu Chi Hospital, The Buddhist Medical Foundation, New Taipei City, Taiwan4School of Medicine, Buddhist Tzu Chi University, Hualien, Taiwan5Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan6Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan7Department of Applied Chemistry, National Chi Nan University, Nantou, Taiwan5Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan6Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan8Department of Senior Citizen Service Management, National Taichung University of Science and Technology, Taichung, Taiwan9Department of Urology, MacKay Memorial Hospital, Taipei, Taiwan0Mackay Medical College, Taipei, Taiwan1Institute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei, Taiwan9Department of Urology, MacKay Memorial Hospital, Taipei, Taiwan0Mackay Medical College, Taipei, Taiwan2Department of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, Taiwan3Department of Health and Nutrition Biotechnology, Asian University, Taichung, Taiwan2Department of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, Taiwan4Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan4Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan5Department of Urology Taiwan Adventist Hospital, Taipei, Taiwan5Department of Urology Taiwan Adventist Hospital, Taipei, Taiwan6College of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan7Department of Urology, Cardinal Tien Hospital, New Taipei City, Taiwan8Department of Life Science, College of Science, National Taiwan Normal University, Taipei, Taiwan9Division of Urology, Department of Surgery, Taipei City Hospital renai branch, Taipei, Taiwan0Department of Urology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan1Department of Urology, College of Medicine, National Taiwan University Hospital, Taipei, Taiwan2Department of Urology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan3Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan4TMU Research Center of Urology and Kidney (TMU-RCUK), Taipei Medical University, Taipei, Taiwan5Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Chia-Yi, Taiwan6Chang Gung University of Science and Technology, Chia-Yi, Taiwan7Department of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan4School of Medicine, Buddhist Tzu Chi University, Hualien, Taiwan8Department of Surgery, Taipei Tzu chi Hospital, The Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan9Department of Urology, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan0Division of Urology, Department of Surgery, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan1School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan2Department of Chemical Engineering and Biotechnology and Graduate Institute of Biochemical and Biomedical Engineering, National Taipei University of Technology, Taipei, Taiwan3Department of Urology, China Medical University and Hospital, Taichung, Taiwan4School of Medicine, China Medical University, Taichung, TaiwanInstitute of Biomedical Engineering, National Taiwan University, Taipei, TaiwanDivisions of Urology, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan5Department of Electrical Engineering, Yuan Ze University, Taoyuan, TaiwanObjectivesTo evaluate the predictive role of pre-nephroureterectomy (NU) hydronephrosis on post-NU renal function (RF) change and preserved eligibility rate for adjuvant therapy in patients with upper tract urothelial carcinoma (UTUC).Patients and methodsThis retrospective study collected data of 1018 patients from the Taiwan UTUC Collaboration Group registry of 26 institutions. The patients were divided into two groups based on the absence or presence of pre-NU hydronephrosis. Estimated glomerular filtration rate (eGFR) was calculated pre- and post-NU respectively. The one month post-NU RF change, chronic kidney disease (CKD) progression, and the preserved eligibility rate for adjuvant therapy were compared for each CKD stage.Results404 (39.2%) patients without and 614 (60.8%) patients with pre-NU hydronephrosis were enrolled. The median post-NU change in the eGFR was significantly lower in the hydronephrosis group (-3.84 versus -12.88, p<0.001). Pre-NU hydronephrosis was associated with a lower post-NU CKD progression rate (33.1% versus 50.7%, p< 0.001) and was an independent protective factor for RF decline after covariate adjustment (OR=0.46, p<0.001). Patients with pre-NU hydronephrosis had a higher preserved eligibility rate for either adjuvant cisplatin-based chemotherapy (OR=3.09, 95%CI 1.95–4.69) or immune-oncology therapy (OR=2.31, 95%CI 1.23–4.34).ConclusionPre-NU hydronephrosis is an independent protective predictor for post-NU RF decline, CKD progression, and eligibility for adjuvant therapy. With cautious selection for those unfavorably prognostic, non-metastatic UTUC patients with preoperative hydronephrosis, adjuvant rather than neoadjuvant therapy could be considered due to higher chance of preserving eligibility.https://www.frontiersin.org/articles/10.3389/fonc.2023.944321/fullhydronephrosisnephroureterectomyrenal functionupper tract urothelial carcinomachronic kidney diseaseadjuvant therapy
spellingShingle Pai-Yu Cheng
Pai-Yu Cheng
Hsiang-Ying Lee
Hsiang-Ying Lee
Hsiang-Ying Lee
Hsiang-Ying Lee
Wei-Ming Li
Wei-Ming Li
Wei-Ming Li
Wei-Ming Li
Wei-Ming Li
Steven K. Huang
Steven K. Huang
Chien-Liang Liu
I-Hsuan Alan Chen
Jen-Tai Lin
Chi-Wen Lo
Chih-Chin Yu
Chih-Chin Yu
Shian-Shiang Wang
Shian-Shiang Wang
Shian-Shiang Wang
Chuan-Shu Chen
Chuan-Shu Chen
Chuan-Shu Chen
Jen-Shu Tseng
Jen-Shu Tseng
Jen-Shu Tseng
Wun-Rong Lin
Wun-Rong Lin
Jou Yeong-Chin
Jou Yeong-Chin
Ian-Seng Cheong
Yuan-Hong Jiang
Yu Khun Lee
Yung-Tai Chen
Shin-Hong Chen
Bing-Juin Chiang
Bing-Juin Chiang
Bing-Juin Chiang
Thomas Y. Hsueh
Thomas Y. Hsueh
Chao-Yuan Huang
Chia-Chang Wu
Chia-Chang Wu
Chia-Chang Wu
Wei Yu Lin
Wei Yu Lin
Wei Yu Lin
Yao-Chou Tsai
Yao-Chou Tsai
Yao-Chou Tsai
Kai-Jie Yu
Kai-Jie Yu
Kai-Jie Yu
Chi-Ping Huang
Chi-Ping Huang
Yi-You Huang
Chung-You Tsai
Chung-You Tsai
Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinoma
Frontiers in Oncology
hydronephrosis
nephroureterectomy
renal function
upper tract urothelial carcinoma
chronic kidney disease
adjuvant therapy
title Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinoma
title_full Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinoma
title_fullStr Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinoma
title_full_unstemmed Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinoma
title_short Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinoma
title_sort preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinoma
topic hydronephrosis
nephroureterectomy
renal function
upper tract urothelial carcinoma
chronic kidney disease
adjuvant therapy
url https://www.frontiersin.org/articles/10.3389/fonc.2023.944321/full
work_keys_str_mv AT paiyucheng preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT paiyucheng preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT hsiangyinglee preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT hsiangyinglee preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT hsiangyinglee preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT hsiangyinglee preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT weimingli preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT weimingli preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT weimingli preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT weimingli preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT weimingli preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT stevenkhuang preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT stevenkhuang preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT chienliangliu preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT ihsuanalanchen preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT jentailin preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT chiwenlo preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT chihchinyu preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT chihchinyu preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT shianshiangwang preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT shianshiangwang preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT shianshiangwang preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT chuanshuchen preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT chuanshuchen preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT chuanshuchen preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT jenshutseng preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT jenshutseng preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT jenshutseng preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT wunronglin preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT wunronglin preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT jouyeongchin preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT jouyeongchin preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT iansengcheong preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT yuanhongjiang preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT yukhunlee preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT yungtaichen preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT shinhongchen preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT bingjuinchiang preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT bingjuinchiang preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT bingjuinchiang preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT thomasyhsueh preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT thomasyhsueh preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT chaoyuanhuang preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT chiachangwu preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT chiachangwu preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT chiachangwu preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT weiyulin preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT weiyulin preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT weiyulin preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT yaochoutsai preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT yaochoutsai preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT yaochoutsai preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT kaijieyu preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT kaijieyu preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT kaijieyu preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT chipinghuang preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT chipinghuang preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT yiyouhuang preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT chungyoutsai preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma
AT chungyoutsai preoperativehydronephrosisisanindependentprotectivefactorofrenalfunctiondeclineafternephroureterectomyforuppertracturothelialcarcinoma